Annual Accounts Payable
$3.31 M
+$911.00 K+37.96%
December 31, 2023
Summary
- As of February 7, 2025, IMNM annual accounts payable is $3.31 million, with the most recent change of +$911.00 thousand (+37.96%) on December 31, 2023.
- During the last 3 years, IMNM annual accounts payable has risen by +$2.12 million (+178.94%).
- IMNM annual accounts payable is now at all-time high.
Performance
IMNM Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$3.52 M
-$3.53 M-50.08%
September 30, 2024
Summary
- As of February 7, 2025, IMNM quarterly accounts payable is $3.52 million, with the most recent change of -$3.53 million (-50.08%) on September 30, 2024.
- Over the past year, IMNM quarterly accounts payable has increased by +$207.00 thousand (+6.25%).
- IMNM quarterly accounts payable is now -51.00% below its all-time high of $7.18 million, reached on March 31, 2024.
Performance
IMNM Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
IMNM Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +38.0% | +6.3% |
| 3 y3 years | +178.9% | +46.6% |
| 5 y5 years | +600.0% | +46.6% |
IMNM Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +38.0% | -51.0% | +46.6% |
| 5 y | 5-year | at high | +504.2% | -51.0% | +542.0% |
| alltime | all time | at high | +600.0% | -51.0% | +542.0% |
Immunome Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.52 M(-50.1%) |
| Jun 2024 | - | $7.05 M(-1.8%) |
| Mar 2024 | - | $7.18 M(+116.8%) |
| Dec 2023 | $3.31 M(+38.0%) | $3.31 M(+18.8%) |
| Sep 2023 | - | $2.79 M(-24.7%) |
| Jun 2023 | - | $3.70 M(+11.8%) |
| Mar 2023 | - | $3.31 M(+37.9%) |
| Dec 2022 | $2.40 M | $2.40 M(-23.5%) |
| Sep 2022 | - | $3.14 M(-40.3%) |
| Jun 2022 | - | $5.26 M(+35.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $3.89 M(+26.4%) |
| Dec 2021 | $3.08 M(+159.2%) | $3.08 M(-6.1%) |
| Sep 2021 | - | $3.28 M(+83.1%) |
| Jun 2021 | - | $1.79 M(-39.5%) |
| Mar 2021 | - | $2.96 M(+149.2%) |
| Dec 2020 | $1.19 M(+116.6%) | $1.19 M(-54.8%) |
| Sep 2020 | - | $2.63 M(+84.7%) |
| Jun 2020 | - | $1.42 M(+159.5%) |
| Dec 2019 | $548.00 K(+15.9%) | $548.00 K |
| Dec 2018 | $473.00 K | - |
FAQ
- What is Immunome annual accounts payable?
- What is the all time high annual accounts payable for Immunome?
- What is Immunome annual accounts payable year-on-year change?
- What is Immunome quarterly accounts payable?
- What is the all time high quarterly accounts payable for Immunome?
- What is Immunome quarterly accounts payable year-on-year change?
What is Immunome annual accounts payable?
The current annual accounts payable of IMNM is $3.31 M
What is the all time high annual accounts payable for Immunome?
Immunome all-time high annual accounts payable is $3.31 M
What is Immunome annual accounts payable year-on-year change?
Over the past year, IMNM annual accounts payable has changed by +$911.00 K (+37.96%)
What is Immunome quarterly accounts payable?
The current quarterly accounts payable of IMNM is $3.52 M
What is the all time high quarterly accounts payable for Immunome?
Immunome all-time high quarterly accounts payable is $7.18 M
What is Immunome quarterly accounts payable year-on-year change?
Over the past year, IMNM quarterly accounts payable has changed by +$207.00 K (+6.25%)